# | Title | Journal | Year | Citations |
---|
1 | International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Journal of Thrombosis and Haemostasis | 2006 | 6,039 |
2 | Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia | Journal of Thrombosis and Haemostasis | 2020 | 4,615 |
3 | Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients | Journal of Thrombosis and Haemostasis | 2005 | 3,778 |
4 | Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy | Journal of Thrombosis and Haemostasis | 2020 | 2,925 |
5 | Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients | Journal of Thrombosis and Haemostasis | 2010 | 1,826 |
6 | ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 | Journal of Thrombosis and Haemostasis | 2020 | 1,513 |
7 | Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia | Journal of Thrombosis and Haemostasis | 2020 | 1,482 |
8 | Fibrinogen and fibrin structure and functions | Journal of Thrombosis and Haemostasis | 2005 | 1,382 |
9 | Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy | Journal of Thrombosis and Haemostasis | 2007 | 1,309 |
10 | Incidence of venous thromboembolism in hospitalized patients with COVID‐19 | Journal of Thrombosis and Haemostasis | 2020 | 1,227 |
11 | Incidence and mortality of venous thrombosis: a population-based study | Journal of Thrombosis and Haemostasis | 2007 | 1,134 |
12 | Hypercoagulability of COVID‐19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis | Journal of Thrombosis and Haemostasis | 2020 | 1,070 |
13 | Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor | Journal of Thrombosis and Haemostasis | 2006 | 1,061 |
14 | Update of the guidelines for lupus anticoagulant detection | Journal of Thrombosis and Haemostasis | 2009 | 1,055 |
15 | D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19 | Journal of Thrombosis and Haemostasis | 2020 | 986 |
16 | High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patients | Journal of Thrombosis and Haemostasis | 2020 | 984 |
17 | Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trial | Journal of Thrombosis and Haemostasis | 2007 | 942 |
18 | Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings | Journal of Thrombosis and Haemostasis | 2006 | 916 |
19 | Protease-activated receptors in hemostasis, thrombosis and vascular biology | Journal of Thrombosis and Haemostasis | 2005 | 909 |
20 | Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTH | Journal of Thrombosis and Haemostasis | 2015 | 889 |
21 | A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score | Journal of Thrombosis and Haemostasis | 2010 | 864 |
22 | Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta‐analysis | Journal of Thrombosis and Haemostasis | 2010 | 813 |
23 | The procoagulant pattern of patients with COVID‐19 acute respiratory distress syndrome | Journal of Thrombosis and Haemostasis | 2020 | 791 |
24 | Neutrophil extracellular traps promote deep vein thrombosis in mice | Journal of Thrombosis and Haemostasis | 2012 | 741 |
25 | Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing | Journal of Thrombosis and Haemostasis | 2014 | 698 |
26 | Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel | Journal of Thrombosis and Haemostasis | 2007 | 668 |
27 | The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage | Journal of Thrombosis and Haemostasis | 2007 | 627 |
28 | Thrombopoietin: a tool for understanding thrombopoiesis | Journal of Thrombosis and Haemostasis | 2003 | 622 |
29 | ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders | Journal of Thrombosis and Haemostasis | 2010 | 607 |
30 | Multiple roles of the endothelial cell protein C receptor | Journal of Thrombosis and Haemostasis | 2007 | 589 |
31 | Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration | Journal of Thrombosis and Haemostasis | 2014 | 577 |
32 | Incidence of venous thrombosis in a large cohort of 66 329 cancer patients: results of a record linkage study | Journal of Thrombosis and Haemostasis | 2006 | 568 |
33 | Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study | Journal of Thrombosis and Haemostasis | 2008 | 560 |
34 | In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939-an oral, direct Factor Xa inhibitor | Journal of Thrombosis and Haemostasis | 2005 | 558 |
35 | Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19 | Journal of Thrombosis and Haemostasis | 2020 | 547 |
36 | Fibrin structure and wound healing | Journal of Thrombosis and Haemostasis | 2006 | 546 |
37 | The platelet contribution to cancer progression | Journal of Thrombosis and Haemostasis | 2011 | 545 |
38 | A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)1 | Journal of Thrombosis and Haemostasis | 2005 | 534 |
39 | Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial | Journal of Thrombosis and Haemostasis | 2007 | 534 |
40 | Definitions in hemophilia: communication from the SSC of the ISTH | Journal of Thrombosis and Haemostasis | 2014 | 530 |
41 | Thromboinflammation and the hypercoagulability of COVID‐19 | Journal of Thrombosis and Haemostasis | 2020 | 529 |
42 | Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome | Journal of Thrombosis and Haemostasis | 2010 | 527 |
43 | Microparticle-associated tissue factor activity: a link between cancer and thrombosis? | Journal of Thrombosis and Haemostasis | 2007 | 506 |
44 | What is all that thrombin for? | Journal of Thrombosis and Haemostasis | 2003 | 480 |
45 | A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD) | Journal of Thrombosis and Haemostasis | 2006 | 478 |
46 | Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes | Journal of Thrombosis and Haemostasis | 2012 | 473 |
47 | International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer | Journal of Thrombosis and Haemostasis | 2013 | 469 |
48 | Platelet functions beyond hemostasis | Journal of Thrombosis and Haemostasis | 2009 | 465 |
49 | Pathological evidence of pulmonary thrombotic phenomena in severe COVID‐19 | Journal of Thrombosis and Haemostasis | 2020 | 461 |
50 | Tissue plasminogen activator (tPA) treatment for COVID‐19 associated acute respiratory distress syndrome (ARDS): A case series | Journal of Thrombosis and Haemostasis | 2020 | 456 |